Cleared Traditional

K802268 - CRC(CYANMETHEMOGLOBIN REAGENT CONCENT

K802268 is the FDA 510(k) clearance for CRC(CYANMETHEMOGLOBIN REAGENT CONCENT by R&D Systems, Inc.. It is a Class 2 Hematology device (product code KHG) cleared through the Traditional 510(k) pathway after a 106-day FDA review.

K802268 · R&D Systems, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1980
Decision
106d
Days
Class 2
Risk

K802268 is an FDA 510(k) clearance for the CRC(CYANMETHEMOGLOBIN REAGENT CONCENT. Classified as Whole Blood Hemoglobin Determination (product code KHG), Class II - Special Controls.

Submitted by R&D Systems, Inc. (Mchenry, US). The FDA issued a Cleared decision on December 31, 1980 after a review of 106 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7500 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all R&D Systems, Inc. devices

Submission Details

510(k) Number K802268 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 16, 1980
Decision Date December 31, 1980
Days to Decision 106 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
7d faster than avg
Panel avg: 113d · This submission: 106d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KHG Whole Blood Hemoglobin Determination
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7500
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - KHG Whole Blood Hemoglobin Determination

All 19
Devices cleared under the same product code (KHG) and FDA review panel - the closest regulatory comparables to K802268.
SERALYZER HEMOGLOBIN TEST MODULE
K822045 · Miles Laboratories, Inc. · Jul 1982
CYANMETHEMOGLOBIN TEST
K820596 · Boehringer Mannheim Corp. · Mar 1982
AMES SERA-PAK HEMOGLOBIN REAGENT
K803248 · Miles Laboratories, Inc. · Jan 1981
COMPUR M-1000 MINI-PHOTOMETER
K800059 · Miles Laboratories, Inc. · Apr 1980
OXIMETER, CO-, IL MODEL 282
K760208 · Instrumentation Laboratory CO · Jul 1976